FIELD: medicine.
SUBSTANCE: invention relates to the field of biotechnology, specifically to vaccines that contain antigens and adjuvant, which can be used in medicine. Recombinantly, an adjuvant is obtained from the group of recombinant mistletoe lectins of white, without glycosylation, which is used in the vaccine, which in turn is used as a medicament and composition.
EFFECT: invention makes it possible to obtain an effective vaccine containing one antigen or more and at least one adjuvant.
13 cl, 8 dwg, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS FOR THERAPEUTIC APPLICATION | 2004 |
|
RU2362586C2 |
IMMUNOSTIMULATING OLIGONUCLEOTIDES | 2009 |
|
RU2477753C2 |
AGENTS AND METHODS OF TREATING HEPATITIS B VIRUS | 2017 |
|
RU2740802C2 |
IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2012 |
|
RU2610690C2 |
VACCINE COMPOSITION POTENTIATED WITH DNA AND ANTIGEN COMBINATION | 2002 |
|
RU2294212C2 |
IMPROVED IMMUNOLOGICAL COMPOSITION | 2012 |
|
RU2664730C2 |
COMPOSITION FOR STIMULATING DENDRITIC CELL MATURATION, CONTAINING HYBRID PROTEIN RV2299C/ESAT-6 | 2017 |
|
RU2733886C2 |
PHARMACUTICAL, CONTAINING RECOMBINANT MISTLETOE LECTIN, FOR TREATMENT OF MELANOTIC CANCER | 2012 |
|
RU2639445C2 |
IMMUNOGENIC SUBSTANCES CONTAINING ADJUVANT OF POLYINOSINE ACID AND POLYCYTIDYLIC ACID | 2006 |
|
RU2462264C2 |
METHODS OF MALARIA VACCINATION | 2003 |
|
RU2356577C9 |
Authors
Dates
2018-08-17—Published
2012-06-27—Filed